Unknown

Dataset Information

0

Nuclease-mediated gene editing by homologous recombination of the human globin locus.


ABSTRACT: Tal-effector nucleases (TALENs) are engineered proteins that can stimulate precise genome editing through specific DNA double-strand breaks. Sickle cell disease and β-thalassemia are common genetic disorders caused by mutations in β-globin, and we engineered a pair of highly active TALENs that induce modification of 54% of human β-globin alleles near the site of the sickle mutation. These TALENS stimulate targeted integration of therapeutic, full-length beta-globin cDNA to the endogenous β-globin locus in 19% of cells prior to selection as quantified by single molecule real-time sequencing. We also developed highly active TALENs to human γ-globin, a pharmacologic target in sickle cell disease therapy. Using the β-globin and γ-globin TALENs, we generated cell lines that express GFP under the control of the endogenous β-globin promoter and tdTomato under the control of the endogenous γ-globin promoter. With these fluorescent reporter cell lines, we screened a library of small molecule compounds for their differential effect on the transcriptional activity of the endogenous β- and γ-globin genes and identified several that preferentially upregulate γ-globin expression.

SUBMITTER: Voit RA 

PROVIDER: S-EPMC3902937 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nuclease-mediated gene editing by homologous recombination of the human globin locus.

Voit Richard A RA   Hendel Ayal A   Pruett-Miller Shondra M SM   Porteus Matthew H MH  

Nucleic acids research 20131023 2


Tal-effector nucleases (TALENs) are engineered proteins that can stimulate precise genome editing through specific DNA double-strand breaks. Sickle cell disease and β-thalassemia are common genetic disorders caused by mutations in β-globin, and we engineered a pair of highly active TALENs that induce modification of 54% of human β-globin alleles near the site of the sickle mutation. These TALENS stimulate targeted integration of therapeutic, full-length beta-globin cDNA to the endogenous β-globi  ...[more]

Similar Datasets

| S-EPMC3776632 | biostudies-literature
| S-EPMC4892491 | biostudies-literature
| S-EPMC3035666 | biostudies-literature
| S-EPMC11648996 | biostudies-literature
| S-EPMC5127288 | biostudies-literature
| S-EPMC5835144 | biostudies-literature
| S-EPMC11464842 | biostudies-literature
| S-EPMC3159483 | biostudies-literature
| S-EPMC6503098 | biostudies-literature
| S-EPMC3966116 | biostudies-literature